Journal of general internal medicine
-
Disparities in access to anti-SARS-CoV-2 monoclonal antibodies have not been well characterized. ⋯ High-risk ambulatory patients with COVID-19 who identified as Hispanic/Latinx or Black were less likely to receive monoclonal antibody therapy in univariate analysis, a finding not explained by patient refusal. Multivariable and spatial analyses suggested insurance status, language, and social vulnerability contributed to racial disparities.